Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$40.27 - $56.99 $5.23 Million - $7.4 Million
-129,800 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$47.43 - $84.23 $4.49 Million - $7.97 Million
-94,580 Reduced 42.15%
129,800 $6.25 Million
Q2 2021

Aug 12, 2021

SELL
$73.06 - $97.7 $1.19 Million - $1.59 Million
-16,230 Reduced 6.75%
224,380 $19 Million
Q1 2021

May 12, 2021

SELL
$70.43 - $97.42 $121,843 - $168,536
-1,730 Reduced 0.71%
240,610 $20.2 Million
Q4 2020

Feb 12, 2021

SELL
$48.9 - $75.26 $777,510 - $1.2 Million
-15,900 Reduced 6.16%
242,340 $18.2 Million
Q3 2020

Nov 12, 2020

SELL
$37.23 - $50.97 $461,651 - $632,028
-12,400 Reduced 4.58%
258,240 $12.8 Million
Q2 2020

Aug 13, 2020

SELL
$28.78 - $46.83 $170,089 - $276,765
-5,910 Reduced 2.14%
270,640 $10.4 Million
Q1 2020

May 13, 2020

SELL
$25.53 - $70.14 $63,569 - $174,648
-2,490 Reduced 0.89%
276,550 $8.53 Million
Q4 2019

Feb 14, 2020

BUY
$54.18 - $65.64 $4.02 Million - $4.87 Million
74,190 Added 36.22%
279,040 $15.2 Million
Q3 2019

Nov 12, 2019

BUY
$58.58 - $83.91 $85,526 - $122,508
1,460 Added 0.72%
204,850 $12.8 Million
Q2 2019

Aug 07, 2019

SELL
$63.59 - $78.71 $142,441 - $176,310
-2,240 Reduced 1.09%
203,390 $15.3 Million
Q1 2019

May 13, 2019

SELL
$50.75 - $80.54 $57,855 - $91,815
-1,140 Reduced 0.55%
205,630 $16.1 Million
Q4 2018

Feb 12, 2019

SELL
$52.18 - $67.93 $1.26 Million - $1.64 Million
-24,080 Reduced 10.43%
206,770 $11.6 Million
Q3 2018

Nov 13, 2018

SELL
$38.13 - $68.37 $138,793 - $248,866
-3,640 Reduced 1.55%
230,850 $15 Million
Q2 2018

Aug 10, 2018

SELL
$27.62 - $44.51 $246,646 - $397,474
-8,930 Reduced 3.67%
234,490 $9.53 Million
Q1 2018

May 11, 2018

SELL
$26.05 - $34.5 $345,944 - $458,160
-13,280 Reduced 5.17%
243,420 $7.51 Million
Q4 2017

Feb 09, 2018

BUY
$24.5 - $36.01 $6.29 Million - $9.24 Million
256,700
256,700 $6.58 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.